Patient Information

Rises in LDL and HDL cholesterol, triglycerides tied to lower diabetes risk


 

Higher levels of LDL cholesterol, HDL cholesterol, and triglycerides over a lifetime are protective against type 2 diabetes, a Mendelian randomization study has shown. Jon White, PhD, of University College London and his co-investigators sought to shed light on the role of the most commonly measured lipid fractions—LDL cholesterol, HDL cholesterol, and triglycerides—in the development of coronary artery disease and diabetes, particularly the observed link between statin therapy and an increased risk of diabetes. More on the study, and how the results can help to identify the potential effects of lipid-modifying drugs, is available at Family Practice News : http://www.familypracticenews.com/specialty-focus/cardiology/single-article-page/rises-in-ldl-and-hdl-cholesterol-triglycerides-tied-to-lower-diabetes-risk/1c99fd4b400f60185df3f4de7d895f5f.html.

Recommended Reading

Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
Type 2 Diabetes ICYMI
FDA official: We’re monitoring DIY artificial pancreas boom
Type 2 Diabetes ICYMI
Endocrinologist links nighttime hypoglycemia to many ills
Type 2 Diabetes ICYMI
Sleep doctor: Less than 7 hours can worsen diabetes
Type 2 Diabetes ICYMI
Evidence doesn’t support tight glycemic control
Type 2 Diabetes ICYMI
New Cancer Data & Trends
Type 2 Diabetes ICYMI
Experts: Insulin apps can pose major risks
Type 2 Diabetes ICYMI
Correction: Pancreatectomy and islet cell autotransplantation
Type 2 Diabetes ICYMI
Type 2 diabetes peer-led intervention in primary care tied to improved depression symptoms
Type 2 Diabetes ICYMI
Quality Measure Attainment After Add-on Therapy of Both Saxagliptin and Dapagliflozin to Metformin Versus Single Add-On of Saxagliptin or Dapagliflozin
Type 2 Diabetes ICYMI